Sarah L. Hissen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sarah L. Hissen has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Qi Fu
Texas Health Presbyterian Hospital Dallas
14 shared publications - Takuro Washio
Texas Health Presbyterian Hospital Dallas
9 shared publications - Andrew W. D'SOuza
Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry University of Alberta Edmonton Alberta Canada
8 shared publications - Ryosuke Takeda
Laboratory of Neuromuscular Biomechanics, School of Health and Sport Sciences, Chukyo University, Toyota, Japan
6 shared publications Belinda Sanchez
Texas Health Presbyterian Hospital Dallas
5 shared publications- Joel Kevin Shoemaker
Western University
5 shared publications
Latest Publications
- 1 December 2026
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 141 (6) , 1485-1494
Intensity-dependent modulation of sympathetic neurocirculatory control during incremental rhythmic handgrip exercise in humans
Recent work has debated the existence of an exercise intensity-specific onset threshold for muscle sympathetic nerve activity (MSNA) during rhythmic handgrip exercise and whether MSNA recorded in the inactive limb reflects vasoconstrictor signaling within contracting muscle. The findings of the present study indicate that MSNA exhibits an exercise intensity onset threshold below what was previously proposed, and that MSNA recorded in a resting limb does not reflect sympathetic vasoconstrictor signaling within contracting muscle.
- 1 December 2026
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 141 (6) , 1485-1494
Intensity-dependent modulation of sympathetic neurocirculatory control during incremental rhythmic handgrip exercise in humans
Recent work has debated the existence of an exercise intensity-specific onset threshold for muscle sympathetic nerve activity (MSNA) during rhythmic handgrip exercise and whether MSNA recorded in the inactive limb reflects vasoconstrictor signaling within contracting muscle. The findings of the present study indicate that MSNA exhibits an exercise intensity onset threshold below what was previously proposed, and that MSNA recorded in a resting limb does not reflect sympathetic vasoconstrictor signaling within contracting muscle.
- Open Access
- 1 October 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 331 (4) , H1380-H1389
Sympathetic vascular transduction in adults with hypertension and obesity-associated hypertension
Sympathetic vascular transduction is blunted in hypertensive adults relative to normotensive adults, which is in line with compensatory downregulation of vascular transduction to offset elevated sympathetic vasomotor outflow. The compensatory downregulation of sympathetic vascular transduction is less apparent in obesity-associated hypertension, despite no detectable difference in transduction to blood pressure between groups. Our data provide insight regarding differential sympathetic-vascular mechanisms of blood pressure control in adults with hypertension and obesity-associated hypertension.
- 1 October 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 331 (4) , H1380-H1389
Open AccessSympathetic vascular transduction in adults with hypertension and obesity-associated hypertension
Sympathetic vascular transduction is blunted in hypertensive adults relative to normotensive adults, which is in line with compensatory downregulation of vascular transduction to offset elevated sympathetic vasomotor outflow. The compensatory downregulation of sympathetic vascular transduction is less apparent in obesity-associated hypertension, despite no detectable difference in transduction to blood pressure between groups. Our data provide insight regarding differential sympathetic-vascular mechanisms of blood pressure control in adults with hypertension and obesity-associated hypertension.
- 30 July 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
Sex-specific association between obesity and sympathetic nerve activity in HFpEF
Background: Heart failure with preserved ejection fraction (HFpEF) is more prevalent in women than in men, and most patients with HFpEF are overweight or obese in the United States. However, whether the impact of obesity on autonomic dysregulation and inflammation differs by sex in HFpEF remains unknown. We investigated sex-specific associations between obesity, inflammation, and muscle sympathetic nerve activity (MSNA) in patients with HFpEF. Methods: In 57 HFpEF patients (mean±SD; 71±7 years; 37 women, 20 men) and 69 non-HFpEF controls (70±6 years; 43 women, 26 men), body mass index (BMI), MSNA, and C-reactive protein (CRP) were measured during supine rest. Results: A significant sex-by–BMI interaction was observed for the association between BMI and MSNA (Pinteraction=0.047), as well as BMI and CRP (Pinteraction=0.012). The slopes of these associations were steeper in women than men. Women with HFpEF had greater MSNA than men with HFpEF and control women (P<0.05); however, MSNA was not different between men with HFpEF and control men (P=0.727). The association between CRP and MSNA demonstrated a consistent trend toward sex-specificity (Pinteraction=0.060). In sex-stratified subgroup analyses of patients, MSNA and CRP were higher in women with high body fat assessed by DEXA than those with low body fat, but not in men. Conclusions: These findings identify a sex-specific association between obesity, inflammation, and sympathetic neural activity in HFpEF, characterized by a stronger obesity-related sympathetic activation in women. This pattern provides insight into the role of obesity-related inflammation as a key feature of disease expression in women with HFpEF.
- 30 July 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
Sex-specific association between obesity and sympathetic nerve activity in HFpEF
Background: Heart failure with preserved ejection fraction (HFpEF) is more prevalent in women than in men, and most patients with HFpEF are overweight or obese in the United States. However, whether the impact of obesity on autonomic dysregulation and inflammation differs by sex in HFpEF remains unknown. We investigated sex-specific associations between obesity, inflammation, and muscle sympathetic nerve activity (MSNA) in patients with HFpEF. Methods: In 57 HFpEF patients (mean±SD; 71±7 years; 37 women, 20 men) and 69 non-HFpEF controls (70±6 years; 43 women, 26 men), body mass index (BMI), MSNA, and C-reactive protein (CRP) were measured during supine rest. Results: A significant sex-by–BMI interaction was observed for the association between BMI and MSNA (Pinteraction=0.047), as well as BMI and CRP (Pinteraction=0.012). The slopes of these associations were steeper in women than men. Women with HFpEF had greater MSNA than men with HFpEF and control women (P<0.05); however, MSNA was not different between men with HFpEF and control men (P=0.727). The association between CRP and MSNA demonstrated a consistent trend toward sex-specificity (Pinteraction=0.060). In sex-stratified subgroup analyses of patients, MSNA and CRP were higher in women with high body fat assessed by DEXA than those with low body fat, but not in men. Conclusions: These findings identify a sex-specific association between obesity, inflammation, and sympathetic neural activity in HFpEF, characterized by a stronger obesity-related sympathetic activation in women. This pattern provides insight into the role of obesity-related inflammation as a key feature of disease expression in women with HFpEF.
- 3 June 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (8)
Impact of Gestational Weight Gain and Maternal Weight on Sympathetic Adaptations
BACKGROUND: Excessive gestational weight gain (GWG) may cause maladaptive sympathetic neural responses and increase pregnancy risk, which may differ by maternal body mass index. We hypothesized that excessive GWG would further increase muscle sympathetic nerve activity across gestation, particularly in women with overweight or obesity. METHODS: Ninety pregnant women were studied longitudinally during early and late gestation and postpartum. Participants were classified by body mass index in early pregnancy and by GWG in late pregnancy based on the 2009 Institute of Medicine guidelines, forming 4 groups: normal-weight women with normal (n=17) or excessive GWG (n=26), and overweight/obese women with normal (n=16) or excessive GWG (n=31). Resting systolic and diastolic blood pressure, heart rate, and muscle sympathetic nerve activity were measured. Pregnancy outcomes were obtained from hospital maternity records, and complications were diagnosed according to established clinical criteria. RESULTS: Muscle sympathetic nerve activity increased across gestation and was greater in overweight/obese groups than in normal-weight groups ( P =0.017), with no difference between excessive and normal GWG groups ( P =0.845). Heart rate and systolic blood pressure increased from early to late pregnancy and were higher in overweight/obese groups, irrespective of GWG. Diastolic blood pressure increased most in normal-weight women with excessive GWG ( P <0.05), reaching levels comparable to those in the overweight/obese groups. Among all groups, women with overweight/obesity and excessive GWG had the numerically highest complication rate. CONCLUSIONS: The changes in muscle sympathetic nerve activity across gestation did not differ by GWG, even among women with overweight/obesity, suggesting that the increased risk from excessive GWG is unlikely to be mediated by sympathetic activity.
- 3 June 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (8)
Impact of Gestational Weight Gain and Maternal Weight on Sympathetic Adaptations
BACKGROUND: Excessive gestational weight gain (GWG) may cause maladaptive sympathetic neural responses and increase pregnancy risk, which may differ by maternal body mass index. We hypothesized that excessive GWG would further increase muscle sympathetic nerve activity across gestation, particularly in women with overweight or obesity. METHODS: Ninety pregnant women were studied longitudinally during early and late gestation and postpartum. Participants were classified by body mass index in early pregnancy and by GWG in late pregnancy based on the 2009 Institute of Medicine guidelines, forming 4 groups: normal-weight women with normal (n=17) or excessive GWG (n=26), and overweight/obese women with normal (n=16) or excessive GWG (n=31). Resting systolic and diastolic blood pressure, heart rate, and muscle sympathetic nerve activity were measured. Pregnancy outcomes were obtained from hospital maternity records, and complications were diagnosed according to established clinical criteria. RESULTS: Muscle sympathetic nerve activity increased across gestation and was greater in overweight/obese groups than in normal-weight groups ( P =0.017), with no difference between excessive and normal GWG groups ( P =0.845). Heart rate and systolic blood pressure increased from early to late pregnancy and were higher in overweight/obese groups, irrespective of GWG. Diastolic blood pressure increased most in normal-weight women with excessive GWG ( P <0.05), reaching levels comparable to those in the overweight/obese groups. Among all groups, women with overweight/obesity and excessive GWG had the numerically highest complication rate. CONCLUSIONS: The changes in muscle sympathetic nerve activity across gestation did not differ by GWG, even among women with overweight/obesity, suggesting that the increased risk from excessive GWG is unlikely to be mediated by sympathetic activity.
- 1 November 2025
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 329 (5) , R661-R672
Longitudinal changes in cardiovascular and sympathetic neural responses to static handgrip exercise throughout pregnancy
To our knowledge, this is the first longitudinal study to assess sympathetic neural responses during fatiguing static handgrip exercise across pregnancy. Our findings indicate that cardiovascular and sympathetic neural adaptations to exercise occur throughout pregnancy, regardless of the presence of obesity or pregnancy complications. Notably, central and peripheral mechanisms appear to be regulated differently, ensuring that an adequate pressor response to exercise is maintained during pregnancy and into the postpartum period.
- 1 November 2025
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 329 (5) , R661-R672
Longitudinal changes in cardiovascular and sympathetic neural responses to static handgrip exercise throughout pregnancy
To our knowledge, this is the first longitudinal study to assess sympathetic neural responses during fatiguing static handgrip exercise across pregnancy. Our findings indicate that cardiovascular and sympathetic neural adaptations to exercise occur throughout pregnancy, regardless of the presence of obesity or pregnancy complications. Notably, central and peripheral mechanisms appear to be regulated differently, ensuring that an adequate pressor response to exercise is maintained during pregnancy and into the postpartum period.
- Open Access
- 31 May 2025
- Published by Wiley in The Journal of Physiology
- Vol. 603 (11) , 3329-3340
Functional sympatholysis of neuropeptide Y‐mediated vasoconstriction in humans
Metabolic inhibition of sympathetic vasoconstriction (functional sympatholysis) is essential for adequate perfusion of skeletal muscle during exercise. Neuropeptide Y (NPY) is a neurotransmitter that elicits potent vasoconstriction and is co‐released with noradrenaline during sympathoexcitation. NPY is released from sympathetic nerves during exercise; however, no study has assessed whether NPY‐mediated vasoconstriction is sensitive to metabolic inhibition in humans. We tested the hypothesis that post‐junctional NPY‐mediated vasoconstriction would be sensitive to metabolic inhibition during handgrip exercise to a similar degree as α1‐adrenergic vasoconstriction. In 12 healthy adults (seven male, age: 30 ± 7 years, body mass index: 24.9 ± 3 kg/m2) we measured forearm blood flow (Doppler ultrasound), blood pressure (brachial artery catheter) and heart rate, and calculated changes in forearm vascular conductance (FVC) to local intra‐arterial infusions of phenylephrine (PE; α1‐agonist) or NPY (Y1R‐agonist) during: (1) intra‐arterial infusion of sodium nitroprusside (SNP; nitric oxide donor), a non‐metabolic vasodilatory control, and (2) dynamic rhythmic handgrip exercise (EX; 15% maximal voluntary contraction). As expected, the vasoconstrictor response to PE was attenuated during handgrip exercise compared to SNP (ΔFVC: SNP: −44 ± 25% vs. EX: −17 ± 9%; P = 0.002). Similarly, NPY‐mediated vasoconstriction was blunted during handgrip exercise compared to SNP (ΔFVC: SNP: −32 ± 22% vs. EX: −11 ± 7%; P = 0.029). There was no difference in the magnitude of sympatholysis between PE and NPY (PE: 68 ± 18 vs. NPY: 52 ± 34%; P = 0.28). NPY‐mediated vasoconstriction is sensitive to metabolic inhibition in humans, and the magnitude of sympatholysis is not different from α1‐adrenergic vasoconstriction. image Key points: Neuropeptide Y (NPY) is a neurotransmitter that is co‐released from sympathetic nerve terminals and elicits potent vasoconstriction, particularly during periods of sympathoexcitation. NPY is released from sympathetic nerves during exercise, but it is currently unclear whether NPY‐mediated vasoconstriction is sensitive to metabolic inhibition in humans (i.e. functional sympatholysis). For the first time we have shown that NPY‐mediated vasoconstriction is sensitive to metabolic inhibition during exercise in healthy adults, and that the magnitude of inhibition is similar to the inhibition observed for α1‐adrenergic mediated vasoconstriction.
- 31 May 2025
- Published by Wiley in The Journal of Physiology
- Vol. 603 (11) , 3329-3340
Open AccessFunctional sympatholysis of neuropeptide Y‐mediated vasoconstriction in humans
Metabolic inhibition of sympathetic vasoconstriction (functional sympatholysis) is essential for adequate perfusion of skeletal muscle during exercise. Neuropeptide Y (NPY) is a neurotransmitter that elicits potent vasoconstriction and is co‐released with noradrenaline during sympathoexcitation. NPY is released from sympathetic nerves during exercise; however, no study has assessed whether NPY‐mediated vasoconstriction is sensitive to metabolic inhibition in humans. We tested the hypothesis that post‐junctional NPY‐mediated vasoconstriction would be sensitive to metabolic inhibition during handgrip exercise to a similar degree as α1‐adrenergic vasoconstriction. In 12 healthy adults (seven male, age: 30 ± 7 years, body mass index: 24.9 ± 3 kg/m2) we measured forearm blood flow (Doppler ultrasound), blood pressure (brachial artery catheter) and heart rate, and calculated changes in forearm vascular conductance (FVC) to local intra‐arterial infusions of phenylephrine (PE; α1‐agonist) or NPY (Y1R‐agonist) during: (1) intra‐arterial infusion of sodium nitroprusside (SNP; nitric oxide donor), a non‐metabolic vasodilatory control, and (2) dynamic rhythmic handgrip exercise (EX; 15% maximal voluntary contraction). As expected, the vasoconstrictor response to PE was attenuated during handgrip exercise compared to SNP (ΔFVC: SNP: −44 ± 25% vs. EX: −17 ± 9%; P = 0.002). Similarly, NPY‐mediated vasoconstriction was blunted during handgrip exercise compared to SNP (ΔFVC: SNP: −32 ± 22% vs. EX: −11 ± 7%; P = 0.029). There was no difference in the magnitude of sympatholysis between PE and NPY (PE: 68 ± 18 vs. NPY: 52 ± 34%; P = 0.28). NPY‐mediated vasoconstriction is sensitive to metabolic inhibition in humans, and the magnitude of sympatholysis is not different from α1‐adrenergic vasoconstriction. image Key points: Neuropeptide Y (NPY) is a neurotransmitter that is co‐released from sympathetic nerve terminals and elicits potent vasoconstriction, particularly during periods of sympathoexcitation. NPY is released from sympathetic nerves during exercise, but it is currently unclear whether NPY‐mediated vasoconstriction is sensitive to metabolic inhibition in humans (i.e. functional sympatholysis). For the first time we have shown that NPY‐mediated vasoconstriction is sensitive to metabolic inhibition during exercise in healthy adults, and that the magnitude of inhibition is similar to the inhibition observed for α1‐adrenergic mediated vasoconstriction.
- Open Access
- 1 February 2025
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 328 (2) , H271-H282
The impact of oral contraceptive pill use on sympathetic transduction at rest in young females
This study investigated the impact of OCP use on the transduction of MSNA bursts into regional vasoconstriction and blood pressure in premenopausal females. We demonstrated that females using OCPs exhibit attenuated sympathetic transduction into LVC; however, this does not translate to reductions in sympathetic blood pressure transduction. Collectively, these data indicate that OCP use may alter the local vasoconstrictor response to bursts of MSNA; however, compensatory mechanisms may contribute to maintain sympathetic blood pressure transduction.
- 1 February 2025
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 328 (2) , H271-H282
Open AccessThe impact of oral contraceptive pill use on sympathetic transduction at rest in young females
This study investigated the impact of OCP use on the transduction of MSNA bursts into regional vasoconstriction and blood pressure in premenopausal females. We demonstrated that females using OCPs exhibit attenuated sympathetic transduction into LVC; however, this does not translate to reductions in sympathetic blood pressure transduction. Collectively, these data indicate that OCP use may alter the local vasoconstrictor response to bursts of MSNA; however, compensatory mechanisms may contribute to maintain sympathetic blood pressure transduction.
- 1 August 2024
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 327 (2) , R133-R144
The interactive effects of posture and biological sex on the control of muscle sympathetic nerve activity during rhythmic handgrip exercise
The impact of posture and sex on cardiovascular control during rhythmic handgrip (RHG) exercise is unknown. We show that increases in muscle sympathetic nerve activity (MSNA) during RHG are partly mediated by a reduction in sympathetic baroreflex gain. In addition, males demonstrate larger increases in total MSNA during upright RHG than females. These data indicate that the baroreflex partly mediates increases in MSNA during RHG and that males have a greater sympathetic vasoconstrictor reserve than females.
- 1 August 2024
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 327 (2) , R133-R144
The interactive effects of posture and biological sex on the control of muscle sympathetic nerve activity during rhythmic handgrip exercise
The impact of posture and sex on cardiovascular control during rhythmic handgrip (RHG) exercise is unknown. We show that increases in muscle sympathetic nerve activity (MSNA) during RHG are partly mediated by a reduction in sympathetic baroreflex gain. In addition, males demonstrate larger increases in total MSNA during upright RHG than females. These data indicate that the baroreflex partly mediates increases in MSNA during RHG and that males have a greater sympathetic vasoconstrictor reserve than females.
- 1 April 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (4) , 917-926
Sympathetic Neural Control at Rest and During the Cold Pressor Test in Patients With Heart Failure With Preserved Ejection Fraction
Background: We tested the hypothesis that patients with heart failure with preserved ejection fraction (HFpEF) would have greater muscle sympathetic nerve activity (MSNA) at rest and sympathetic reactivity during a cold pressor test compared with non–heart failure controls. Further, given the importance of the baroreflex modulation of MSNA in the control of blood pressure (BP), we hypothesized that patients with HFpEF would exhibit a reduced sympathetic baroreflex sensitivity. METHODS: Twenty-eight patients with HFpEF and 44 matched controls (mean±SD: 71±8 versus 70±7 years; 9 men/19 women versus 16 men/28 women) were studied. BP, heart rate, and MSNA (microneurography) were measured during 6 to 10 minutes of supine rest and the 2-minute cold pressor test. Spontaneous sympathetic baroreflex sensitivity was assessed during supine rest. Results: Patients with HFpEF had higher resting MSNA burst frequency (39±14 versus 31±12 bursts/min; P =0.020) and lower sympathetic baroreflex sensitivity (−2.83±0.76 versus −3.57±1.19 bursts/100 heartbeats/mm Hg; P =0.019) than controls, but burst incidence was not different between groups (56±19 versus 50±20 bursts/100 heartbeats; P =0.179). During the cold pressor test, increases in MSNA indices did not differ between groups ( P =0.135–0.998), but patients had a smaller increase in diastolic BP (Δ4±6 versus Δ14±11 mm Hg; P <0.001) compared with controls. Conclusions: Despite augmented resting MSNA burst frequency, burst incidence was not significantly different between groups, and sympathetic baroreflex sensitivity was reduced in patients with HFpEF. Furthermore, patients had preserved sympathetic reactivity but attenuated diastolic BP responses during the cold pressor test. These data suggest that, during physiological stress, sympathetic reactivity is intact, but the peripheral pathway for sympathetic vasoconstriction may be impaired in HFpEF.
- 1 April 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (4) , 917-926
Sympathetic Neural Control at Rest and During the Cold Pressor Test in Patients With Heart Failure With Preserved Ejection Fraction
Background: We tested the hypothesis that patients with heart failure with preserved ejection fraction (HFpEF) would have greater muscle sympathetic nerve activity (MSNA) at rest and sympathetic reactivity during a cold pressor test compared with non–heart failure controls. Further, given the importance of the baroreflex modulation of MSNA in the control of blood pressure (BP), we hypothesized that patients with HFpEF would exhibit a reduced sympathetic baroreflex sensitivity. METHODS: Twenty-eight patients with HFpEF and 44 matched controls (mean±SD: 71±8 versus 70±7 years; 9 men/19 women versus 16 men/28 women) were studied. BP, heart rate, and MSNA (microneurography) were measured during 6 to 10 minutes of supine rest and the 2-minute cold pressor test. Spontaneous sympathetic baroreflex sensitivity was assessed during supine rest. Results: Patients with HFpEF had higher resting MSNA burst frequency (39±14 versus 31±12 bursts/min; P =0.020) and lower sympathetic baroreflex sensitivity (−2.83±0.76 versus −3.57±1.19 bursts/100 heartbeats/mm Hg; P =0.019) than controls, but burst incidence was not different between groups (56±19 versus 50±20 bursts/100 heartbeats; P =0.179). During the cold pressor test, increases in MSNA indices did not differ between groups ( P =0.135–0.998), but patients had a smaller increase in diastolic BP (Δ4±6 versus Δ14±11 mm Hg; P <0.001) compared with controls. Conclusions: Despite augmented resting MSNA burst frequency, burst incidence was not significantly different between groups, and sympathetic baroreflex sensitivity was reduced in patients with HFpEF. Furthermore, patients had preserved sympathetic reactivity but attenuated diastolic BP responses during the cold pressor test. These data suggest that, during physiological stress, sympathetic reactivity is intact, but the peripheral pathway for sympathetic vasoconstriction may be impaired in HFpEF.
- 1 January 2024
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 326 (1) , R10-R18
Impact of maternal obesity on resting muscle sympathetic nerve activity during uncomplicated pregnancy: a longitudinal assessment
The impact of maternal obesity on resting muscle sympathetic nerve activity was examined during (early and late) and after uncomplicated pregnancy. Resting muscle sympathetic nerve activity is not different during early pregnancy or postpartum but is significantly elevated in women with obesity during late pregnancy when compared with normal-weight women. Future research is needed to determine if this is linked with an increased risk of adverse outcomes or is required to maintain homeostasis in pregnancy.
- 1 January 2024
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 326 (1) , R10-R18
Impact of maternal obesity on resting muscle sympathetic nerve activity during uncomplicated pregnancy: a longitudinal assessment
The impact of maternal obesity on resting muscle sympathetic nerve activity was examined during (early and late) and after uncomplicated pregnancy. Resting muscle sympathetic nerve activity is not different during early pregnancy or postpartum but is significantly elevated in women with obesity during late pregnancy when compared with normal-weight women. Future research is needed to determine if this is linked with an increased risk of adverse outcomes or is required to maintain homeostasis in pregnancy.